Clinical trial
Transcription Factor Runx2 in Necrotic Femoral Head Tissue: Study Protocol for a Retrospective Non-randomized, Parallel-controlled Clinical Trial
NCT02735538 is registered in ClinicalTrials.gov with Shengjing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcription Factor Runx2 in Necrotic Femoral Head Tissue: Study Protocol for a Retrospective Non-randomized, Parallel-controlled Clinical Trial
- Lead sponsor
- Shengjing Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- December 31, 2011
- Enrollment
- 30 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
osteonecrosis of femoral head